92 related articles for article (PubMed ID: 9767093)
1. Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group.
Kern H; Volk T; Knauer-Schiefer S; Mieth T; Rüstow B; Kox WJ; Schlame M
Biochim Biophys Acta; 1998 Oct; 1394(1):33-42. PubMed ID: 9767093
[TBL] [Abstract][Full Text] [Related]
2. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group.
Tanaka T; Iimori M; Tsukatani H; Tokumura A
Biochim Biophys Acta; 1994 Jan; 1210(2):202-8. PubMed ID: 8280771
[TBL] [Abstract][Full Text] [Related]
3. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725
[TBL] [Abstract][Full Text] [Related]
4. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
[TBL] [Abstract][Full Text] [Related]
5. Effect of synthetic phospholipids on platelet aggregation and serotonin release.
Söling U; Eibl H; Nagel GA; Unger C
Lipids; 1987 Nov; 22(11):868-70. PubMed ID: 3444380
[TBL] [Abstract][Full Text] [Related]
6. The metabolism of 1-acyl-PAF in rabbit platelets and its possible interaction with PAF.
Touqui L; Silva CS; Vargaftig BB
Lipids; 1991 Dec; 26(12):992-6. PubMed ID: 1819755
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor (PAF)-like phospholipids formed during peroxidation of phosphatidylcholines from different foodstuffs.
Tanaka T; Tokumura A; Tsukatani H
Biosci Biotechnol Biochem; 1995 Aug; 59(8):1389-93. PubMed ID: 7549088
[TBL] [Abstract][Full Text] [Related]
8. The enantiomer and the positional isomer of platelet-activating factor.
Tence M; Coëffier E; Polonsky J; Benveniste J
Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
[TBL] [Abstract][Full Text] [Related]
9. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.
Subbanagounder G; Leitinger N; Shih PT; Faull KF; Berliner JA
Circ Res; 1999 Aug; 85(4):311-8. PubMed ID: 10455059
[TBL] [Abstract][Full Text] [Related]
10. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
[TBL] [Abstract][Full Text] [Related]
11. Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase.
Tokumura A; Sumida T; Toujima M; Kogure K; Fukuzawa K; Takahashi Y; Yamamoto S
J Lipid Res; 2000 Jun; 41(6):953-62. PubMed ID: 10828088
[TBL] [Abstract][Full Text] [Related]
12. Unsaturated 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholines (unsaturated platelet-activating factor): aggregation of human platelets after incubation with indomethacin, creatinephosphate/creatinephosphokinase, xylocain and hirudine, and serotonin release after incubation with indomethacin.
Korth R; Mangold HK; Muramatsu T; Zöllner N
Chem Phys Lipids; 1985 Jan; 36(3):209-14. PubMed ID: 4006034
[TBL] [Abstract][Full Text] [Related]
13. Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chain.
Surles JR; Wykle RL; O'Flaherty JT; Salzer WL; Thomas MJ; Snyder F; Piantadosi C
J Med Chem; 1985 Jan; 28(1):73-8. PubMed ID: 4038418
[TBL] [Abstract][Full Text] [Related]
14. 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines: influence on aggregation and [3H]serotonin release of human thrombocytes.
Korth R; Hillmar I; Muramatsu T; Zöllner N
Chem Phys Lipids; 1983 Jul; 33(1):47-53. PubMed ID: 6627525
[TBL] [Abstract][Full Text] [Related]
15. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
16. Activation of human and rabbit blood platelets by synthetic structural analogs of platelet activating factor.
Hadváry P; Baumgartner HR
Thromb Res; 1983 Apr; 30(2):143-56. PubMed ID: 6868019
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of platelet-activating factor in rabbit spermatozoa.
Kumar R; Harper MJ; Hanahan DJ
Arch Biochem Biophys; 1988 Jan; 260(1):497-502. PubMed ID: 3341753
[TBL] [Abstract][Full Text] [Related]
18. Structural identification of oxidized acyl-phosphatidylcholines that induce platelet activation.
Göpfert MS; Siedler F; Siess W; Sellmayer A
J Vasc Res; 2005; 42(2):120-32. PubMed ID: 15665547
[TBL] [Abstract][Full Text] [Related]
19. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
[TBL] [Abstract][Full Text] [Related]
20. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1991; 3(2):225-37. PubMed ID: 1797154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
